Daily Sabah logo

Politics
Diplomacy Legislation War On Terror EU Affairs Elections News Analysis
TÜRKİYE
Istanbul Education Investigations Minorities Expat Corner Diaspora
World
Mid-East Europe Americas Asia Pacific Africa Syrian Crisis Islamophobia
Business
Automotive Economy Energy Finance Tourism Tech Defense Transportation News Analysis
Lifestyle
Health Environment Travel Food Fashion Science Religion History Feature Expat Corner
Arts
Cinema Music Events Portrait Reviews Performing Arts
Sports
Football Basketball Motorsports Tennis
Opinion
Columns Op-Ed Reader's Corner Editorial
PHOTO GALLERY
JOBS ABOUT US RSS PRIVACY CONTACT US
© Turkuvaz Haberleşme ve Yayıncılık 2025

Daily Sabah - Latest & Breaking News from Turkey | Istanbul

  • Politics
    • Diplomacy
    • Legislation
    • War On Terror
    • EU Affairs
    • Elections
    • News Analysis
  • TÜRKİYE
    • Istanbul
    • Education
    • Investigations
    • Minorities
    • Expat Corner
    • Diaspora
  • World
    • Mid-East
    • Europe
    • Americas
    • Asia Pacific
    • Africa
    • Syrian Crisis
    • Islamophobia
  • Business
    • Automotive
    • Economy
    • Energy
    • Finance
    • Tourism
    • Tech
    • Defense
    • Transportation
    • News Analysis
  • Lifestyle
    • Health
    • Environment
    • Travel
    • Food
    • Fashion
    • Science
    • Religion
    • History
    • Feature
    • Expat Corner
  • Arts
    • Cinema
    • Music
    • Events
    • Portrait
    • Reviews
    • Performing Arts
  • Sports
    • Football
    • Basketball
    • Motorsports
    • Tennis
  • Gallery
  • Opinion
    • Columns
    • Op-Ed
    • Reader's Corner
    • Editorial
  • TV
  • Life
  • Health
  • Environment
  • Travel
  • Food
  • Fashion
  • Science
  • Religion
  • History
  • Feature
  • Expat Corner

Do COVID-19 vaccines protect people with a weak immune system?

by ASSOCIATED PRESS

Jul 16, 2021 - 12:40 pm GMT+3
A Thai health official prepares the AstraZeneca (Vaxzevria) COVID-19 vaccine to be administered to people over 50 years of age at a non-hospital vaccination facility set up at a community sports center in Bangkok, Thailand, July 16, 2021. (EPA Photo)
A Thai health official prepares the AstraZeneca (Vaxzevria) COVID-19 vaccine to be administered to people over 50 years of age at a non-hospital vaccination facility set up at a community sports center in Bangkok, Thailand, July 16, 2021. (EPA Photo)
by ASSOCIATED PRESS Jul 16, 2021 12:40 pm

In most cases, the COVID-19 vaccination gives people strong protection against the deadly virus, but is it the same case for people with a weak immune system?

Probably not as well as they do in healthy people, but the shots should offer some protection.

It’s why vaccinations are still recommended for people with immune systems weakened by disease or certain medications. It’s also important that your family, friends and caregivers get vaccinated, which will make it far less likely that they pass on the virus.

About 3% of U.S. adults have weakened immune systems. Among them are people with HIV or AIDS, transplant recipients, some cancer patients and people with autoimmune disorders such as rheumatoid arthritis, inflammatory bowel disease and lupus.

COVID-19 shots weren’t studied in large numbers of people with weak immune systems. But limited data and experience with flu and pneumonia vaccines suggest they won’t work as well as they do in others. That means people with weakened immune systems should keep taking precautions like wearing masks and avoiding large crowds.

“It’s prudent to use all the precautions you were using before you were vaccinated,” said Dr. Ajit Limaye, a transplant expert at the University of Washington Medicine in Seattle.

Although most cancer patients should get vaccinated as soon as they can, people getting stem cell transplant or CAR T-cell therapy should wait at least three months after treatment to get vaccinated, according to guidance from the National Comprehensive Cancer Network. That delay will make sure the vaccines work as well as they can.

For transplant recipients, researchers are looking at whether an extra dose might make the vaccines more effective.

French guidelines recommend a third COVID-19 dose for the immunocompromised, including organ recipients. Israel recently began giving an extra dose of the Pfizer vaccine to transplant patients and others with weak immune systems. Some U.S. transplant recipients seek out a third dose on their own in hopes of more protection even though the federal government hasn’t authorized extra vaccinations.

  • shortlink copied
  • Last Update: Jul 16, 2021 1:43 pm
    KEYWORDS
    covid-19 outbreak coronavirus vaccine research vaccination
    The Daily Sabah Newsletter
    Keep up to date with what’s happening in Turkey, it’s region and the world.
    You can unsubscribe at any time. By signing up you are agreeing to our Terms of Use and Privacy Policy. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
    No Image
    US protesters take to streets for Breonna Taylor
    PHOTOGALLERY
    • POLITICS
    • Diplomacy
    • Legislation
    • War On Terror
    • EU Affairs
    • News Analysis
    • TÜRKİYE
    • Istanbul
    • Education
    • Investigations
    • Minorities
    • Diaspora
    • World
    • Mid-East
    • Europe
    • Americas
    • Asia Pacific
    • Africa
    • Syrian Crisis
    • İslamophobia
    • Business
    • Automotive
    • Economy
    • Energy
    • Finance
    • Tourism
    • Tech
    • Defense
    • Transportation
    • News Analysis
    • Lifestyle
    • Health
    • Environment
    • Travel
    • Food
    • Fashion
    • Science
    • Religion
    • History
    • Feature
    • Expat Corner
    • Arts
    • Cinema
    • Music
    • Events
    • Portrait
    • Performing Arts
    • Reviews
    • Sports
    • Football
    • Basketball
    • Motorsports
    • Tennis
    • Opinion
    • Columns
    • Op-Ed
    • Reader's Corner
    • Editorial
    • Photo gallery
    • DS TV
    • Jobs
    • privacy
    • about us
    • contact us
    • RSS
    © Turkuvaz Haberleşme ve Yayıncılık 2021